Search Results - "Burz, Sebastian D."
-
1
A Guide for Ex Vivo Handling and Storage of Stool Samples Intended for Fecal Microbiota Transplantation
Published in Scientific reports (20-06-2019)“…Owing to the growing recognition of the gut microbiota as a main partner of human health, we are expecting that the number of indications for fecal microbiota…”
Get full text
Journal Article -
2
Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease
Published in International journal of molecular sciences (01-08-2023)“…Non-alcoholic fatty liver disease (NAFLD) affects about 20-40% of the adult population in high-income countries and is now a leading indication for liver…”
Get full text
Journal Article -
3
Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD)
Published in Microorganisms (Basel) (01-01-2021)“…Non-alcoholic fatty liver diseases (NAFLD) are associated with changes in the composition and metabolic activities of the gut microbiota. However, the causal…”
Get full text
Journal Article -
4
Alternative stable states in the intestinal ecosystem: proof of concept in a rat model and a perspective of therapeutic implications
Published in Microbiome (06-11-2020)“…Chronic immune-mediated diseases are rapidly expanding and notoriously difficult to cure. Altered relatively stable intestinal microbiota configurations are…”
Get full text
Journal Article -
5
IAdlercreutzia equolifaciens/I Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease
Published in International journal of molecular sciences (01-07-2023)“…Non-alcoholic fatty liver disease (NAFLD) affects about 20–40% of the adult population in high-income countries and is now a leading indication for liver…”
Get full text
Journal Article